Hair Million promotes hair growth in both women and men. It is made of healthy and safe herbs that have been well documented and in use for thousands of years, especially in Asia. Although these herbs have not yet been scientifically proven by placebo-controlled clinical trials nor the ingedients of the herbs charaterized in laboratory, the herbal formula has been proven efficacious anecdotally in a number of people who experience hair thinning and hair loss. There are other herbs and nutritions that also work in anecdotal cases. For instance, Saw palmetto fruit extract have beens shown effective. Other herbs, such as sage, evening primrose, horse chestnut, horsetail, rosemary have been suggested. B vitamins, especially biotin might help as well.

Hair Million is a finest product that would ward off hair loss and promote hair growth, without side effect. Hair Million should be orally taken as suggested for a few months to see the positive effects: stopping hair thinning, and hair loss, and observing new hair growth. For some individuals, none of the hair growth products or methods would work, and the reasons are not always clear. People with alopecia areata would certainly benefit from Hair Million. Once you know it works for you, you could take it for months and years. It often results in complete restoration of hair.



  • Notch/RBP-J Signaling Regulates Epidermis/Hair Fate Determination of Hair Follicular Stem Cells.
  • Fas and c-kit are involved in the control of hair follicle melanocyte apoptosis and migration in chemotherapy-induced hair loss.
  • The potential role of minoxidil in the hair transplantation setting.
  • Finasteride in the treatment of Taiwanese men with androgenetic alopecia: a 12-month open-label study.
  • Acute Diffuse and Total Alopecia of the Female Scalp. a new subtype of diffuse alopecia areata that has a favorable prognosis.
  • Acute Diffuse and Total Alopecia of the Female Scalp. a new subtype of diffuse alopecia areata that has a favorable prognosis.
  • Dense-packing hair grafting technique for restoration of cicatricial alopecia
  • Role of the Autoimmune Regulator (AIRE) gene in alopecia areata: Strong association of a potentially functional AIRE polymorphism with alopecia universalis.
  • Alopecia areata in children: a clinical profile.
  • The pattern and profile of alopecia areata in Singapore - a study of 219 Asians.
  • Notch/RBP-J Signaling Regulates Epidermis/Hair Fate Determination of Hair Follicular Stem Cells.
  • Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies.
  • 'Cyclic alopecia' in Msx2 mutants: defects in hair cycling and hair shaft differentiation.
  • Female pattern hair loss.
  • Implication of VEGF, steroid hormones and neuropeptides in hair follicle cell responses
  • Dense-packing hair grafting technique for restoration of cicatricial alopecia
  • Postmenopausal frontal fibrosing alopecia.
  • There is no clear association between low serum ferritin and chronic diffuse telogen hair loss.
  • Striae distensae - like lesions. A cause of scarring alopecia among children.
  • Hair Transplantation for Men with Advanced Degrees of Hair Loss
  • Alopecia areata - animal models.
  • The art of repair in surgical hair restoration part I: basic repair strategies.
  • There is no clear association between low serum ferritin and chronic diffuse telogen hair loss.
  • Weekly administration of paclitaxel and pirarubicine for recurrent breast cancer
  • Loose anagen syndrome as a severity factor for trichotillomania.
  • Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies.
  • Langerhans cells that express matrix metalloproteinase 9 increase in human dermis during sensitization to diphenylcyclopropenone in patients with alopecia areata.
  • Steroidogenic isoenzymes in human hair and their potential role in androgenetic alopecia.
  • Hair loss in women with hyperandrogenism: four cases responding to finasteride.
  • Alopecia areata in children: a clinical profile.
  • Acute Diffuse and Total Alopecia of the Female Scalp. a new subtype of diffuse alopecia areata that has a favorable prognosis.
  • Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial.
  • Efficacy and tolerance of a scalp-cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapy.
  • Male androgenetic alopecia.
  • Hair loss during treatment with oral contraceptives
  • Acute Diffuse and Total Alopecia of the Female Scalp. a new subtype of diffuse alopecia areata that has a favorable prognosis.
  • TrichoScan. A new instrument for digital hair analysis
  • Postmenopausal frontal fibrosing alopecia. Report of 3 cases
  • Treatment of hyperandrogenic alopecia in women.
  • Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapy.
  • Epidemiology and genetics of alopecia areata.
  • Primary follicular mucinosis: long-term follow-up of patients younger than 40 years with and without clonal T-cell receptor gene rearrangement.
  • The hair follicle as a target for gene therapy
  • Androgen-inducible TGF-beta1 from balding dermal papilla cells inhibits epithelial cell growth: a clue to understand paradoxical effects of androgen on human hair growth.
  • Diphencyprone immunotherapy alters anti-hair follicle antibody status in patients with alopecia areata.
  • There is no clear association between low serum ferritin and chronic diffuse telogen hair loss.
  • Implication of VEGF, steroid hormones and neuropeptides in hair follicle cell responses
  • There is no clear association between low serum ferritin and chronic diffuse telogen hair loss.
  • Disappearance of pili annulati following an episode of alopecia areata.
  • Male androgenetic alopecia.
  • Androgens and alopecia.
  • Alopecia areata
  • 'Cyclic alopecia' in Msx2 mutants: defects in hair cycling and hair shaft differentiation.
  • Steroidogenic isoenzymes in human hair and their potential role in androgenetic alopecia.
  • Alopecia areata in children: a clinical profile.
  • Inducible, reversible hair loss in transgenic mice.
  • The hair follicle as a target for gene therapy
  • Loss of cell adhesion in Dsg3bal-Pas mice with homozygous deletion mutation (2079del14) in the desmoglein 3 gene.
  • Loss of cell adhesion in Dsg3bal-Pas mice with homozygous deletion mutation (2079del14) in the desmoglein 3 gene.
  • Inducible, reversible hair loss in transgenic mice.
  • Hair pain (trichodynia): frequency and relationship to hair loss and patient gender.
  • Curly bare (cub), a new mouse mutation on chromosome 11 causing skin and hair abnormalities, and a modifier gene (mcub) on chromosome 5.
  • Role of the Autoimmune Regulator (AIRE) gene in alopecia areata: Strong association of a potentially functional AIRE polymorphism with alopecia universalis.
  • Curly bare (cub), a new mouse mutation on chromosome 11 causing skin and hair abnormalities, and a modifier gene (mcub) on chromosome 5.
  • Postmenopausal frontal fibrosing alopecia. Report of 3 cases
  • Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies.
  • Effect of minoxidil on hair growth in androgenic alopecia in women
  • Treatment of hyperandrogenic alopecia in women.
  • Kenogen. A new phase of the hair cycle?
  • Baldness: Does appearance matter?
  • Hair pain (trichodynia): frequency and relationship to hair loss and patient gender.
  • There is no clear association between low serum ferritin and chronic diffuse telogen hair loss.
  • Female pattern hair loss.
  • Notch/RBP-J Signaling Regulates Epidermis/Hair Fate Determination of Hair Follicular Stem Cells.
  • Notch/RBP-J Signaling Regulates Epidermis/Hair Fate Determination of Hair Follicular Stem Cells.
  • Role of the Autoimmune Regulator (AIRE) gene in alopecia areata: Strong association of a potentially functional AIRE polymorphism with alopecia universalis.
  • Steroidogenic isoenzymes in human hair and their potential role in androgenetic alopecia.
  • Baldness: Does appearance matter?
  • There is no clear association between low serum ferritin and chronic diffuse telogen hair loss.
  • A philosophy and strategy for surgical hair restoration: a 10-year experience.



    Hair loss and hair growth online references:

    1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 |